TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11580868

Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Neurotrophin-3 (NT-3)
Number of subjects: 42
Study: 9226488

Group type: EXPERIMENTAL
Intervention: Very Low Calorie Diet (VLCD) 1764 kJ/d (420 kcal/d)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Balanced hypocaloric diet of 6720 kJ/d (1600 kcal/d)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Balanced hypocaloric diet with 1 MJ of VLCD (group C)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Balanced hypocaloric diet without VLCD (group B)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Nutrition powder (1 MJ) taken freely
Number of subjects: 81
Study: 8427339

Group type: EXPERIMENTAL
Intervention: Fish oil (20 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Safflower oil (control)
Number of subjects: 0
Study: 3296854

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia and analgesia (EAA)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard anesthetic and analgesic techniques without EAA
Number of subjects: 53
Study: 30949742

Group type: EXPERIMENTAL
Intervention: B.T. Enema (sodium dihydrogen phosphate + disodium hydrogen phosphate) 135 ml
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no enema)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Both groups (enema and control)
Number of subjects: 95
Study: 29558513

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 46

Group type: COMPARATOR
Intervention: tDCS (anodal and cathodal)
Number of subjects: 46
Study: 26470647

Group type: EXPERIMENTAL
Intervention: DREAMS 2G drug-eluting absorbable metal scaffold
Number of subjects: 123
Study: 26227657

Group type: EXPERIMENTAL
Intervention: Natural drainage
Number of subjects: 141

Group type: COMPARATOR
Intervention: Negative drainage
Number of subjects: 141
Study: 23835329

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22152750

Group type: EXPERIMENTAL
Intervention: Home blood pressure monitoring with nurse-led support
Number of subjects: 381
Study: 19307994

Group type: EXPERIMENTAL
Intervention: 2 mg oregovomab infusion on the same day as chemotherapy (SIM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2 mg oregovomab infusion 1 week after chemotherapy (OWD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2 mg oregovomab infusion (both SIM and OWD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Front-line chemotherapy with carboplatin-paclitaxel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Front-line chemotherapy with carboplatin-paclitaxel combined with oregovomab
Number of subjects: 40
Study: 16391383

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of nitroprusside
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of adenosine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of verapamil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intracoronary injection of nitroglycerin (control group)
Number of subjects: 40
Study: 15172648

Group type: EXPERIMENTAL
Intervention: Empirical Amiodarone
Number of subjects: 214

Group type: COMPARATOR
Intervention: Electrophysiology-guided interventions
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: ICD recipients
Number of subjects: 214
Study: 10647318

Group type: EXPERIMENTAL
Intervention: Functional Restoration (FR) program
Number of subjects: 816

Group type: COMPARATOR
Intervention: Control programs (shorter outpatient programs or no treatment)
Number of subjects: 816
Study: 9302302

Group type: EXPERIMENTAL
Intervention: Percutaneous drainage with albendazole (10 mg/kg/day for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgery (cystectomy)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Percutaneous drainage
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 50
Study: 8331011

Group type: EXPERIMENTAL
Intervention: Subcutaneous recombinant human erythropoietin (r‐HuEPO) at a dose of 200 units/kg/day, five times a week with iron supplements (Fe SO4, 325 mg. p.o., t.i.d.)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group receiving radiotherapy without r‐HuEPO
Number of subjects: 26
Study: 3304952

Group type: EXPERIMENTAL
Intervention: Cyclandelate (3.2 g daily in 2 doses)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cyclandelate with concomitant cholestyramine (16 g daily)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo with concomitant cholestyramine (16 g daily)
Number of subjects: 10
Study: 30249587

Group type: EXPERIMENTAL
Intervention: Simulator-based teaching using the Mentice VIST-Lab CA simulator (n=59, SIM group)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Simulator-based teaching (n=59, SIM group)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control teaching group (n=59, CONT group)
Number of subjects: 118
Study: 26433452

Group type: EXPERIMENTAL
Intervention: Breakfast served in the classroom
Number of subjects: 3944

Group type: COMPARATOR
Intervention: Breakfast served in the cafeteria before school
Number of subjects: 3944

Group type: COMPARATOR
Intervention: Second chance breakfast (in the cafeteria before school and again at first recess)
Number of subjects: 3944
Study: 24057894

Group type: EXPERIMENTAL
Intervention: Progressive resistance strength training (3 sets of 12-15 repetitions, intensity 60-70% of one repetition maximum, four 50-minute sessions per week)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard care (Control group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Both groups (TG and CG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Barthel Index (stairs)
Number of subjects: 56
Study: 22889084

Group type: EXPERIMENTAL
Intervention: Platform-switching implants (58 implants restored with medialised abutments)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard platform implants (56 implants restored with standard matching-diameter abutments)
Number of subjects: 54
Study: 20019316

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study: 18701826

Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, Lactobacillus plantarum PL02)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 22122599

Group type: EXPERIMENTAL
Intervention: Dried blood spots (DBS) assay for guanfacine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Plasma bioanalysis
Number of subjects: 12
Study: 15752888

Group type: EXPERIMENTAL
Intervention: RT/CCT (70 to 72.5 Gy accelerated hyperfractionated RT at 1.25 Gy b.i.d. with 2 cycles of CDDP (12‐20 mg/m(2)/d x 5 days) and continuous infusion 5‐FU (600 mg/m(2)/d x 5 days) during Week 1 and Week 6)
Number of subjects: 159

Group type: COMPARATOR
Intervention: RT alone (control group)
Number of subjects: 159
Study: 11890430

Group type: EXPERIMENTAL
Intervention: Chiropractic technique, lumbar spine flexion‐distraction, combined with manual Trigger Point Therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham chiropractic procedure performed with an instrument combined with effleurage (light massage)
Number of subjects: 39
Study: 9711053

Group type: EXPERIMENTAL
Intervention: 150 micrograms levothyroxine and 150 micrograms iodide (group A, n = 25)
Number of subjects: 48

Group type: COMPARATOR
Intervention: 150 micrograms levothyroxine (group B, n = 23)
Number of subjects: 48
Study: 7653696

Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg/day, flexible dosing)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2672480

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with fluorouracil (5‐FU) (400 mg/m2 i.v., days 1‐5) and lomustine (CCNU) (100 mg/m2 per os on day 5) every 6 weeks for 9 cycles
Number of subjects: 263

Group type: COMPARATOR
Intervention: No further treatment (surgery alone)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with fluorouracil (5‐FU) and lomustine (CCNU)
Number of subjects: 263
Study: 55646

Group type: EXPERIMENTAL
Intervention: Intrapleural B.C.G.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no B.C.G. treatment)
Number of subjects: 60
Study: 11722851

Group type: EXPERIMENTAL
Intervention: Coping intervention for patients with rheumatic diseases
Number of subjects: 0
Study: 31288289

Group type: EXPERIMENTAL
Intervention: HIIT 1:2 (30:60s)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: HIIT 1:4 (30:120s)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: HIIT 1:8 (30:240s)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (Taekwondo training program)
Number of subjects: 47
Study: 28425672

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment
Number of subjects: 2

Group type: COMPARATOR
Intervention: Gaussian model
Number of subjects: 2
Study: 26957290

Group type: EXPERIMENTAL
Intervention: Paracetamol 325 mg/tramadol 37.5 mg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 25379859

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 1236

Group type: COMPARATOR
Intervention: Adjustable gastric banding (AGB)
Number of subjects: 1236
Study: 22591502

Group type: EXPERIMENTAL
Intervention: Intralesional 5-aminolevulinic acid (IL-ALA) plus intense pulsed light (IPL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intense pulsed light (IPL) alone
Number of subjects: 30
Study: 20429333

Group type: EXPERIMENTAL
Intervention: Minimally invasive axillary dissection
Number of subjects: 56

Group type: COMPARATOR
Intervention: Classical axillary dissection
Number of subjects: 56
Study: 18330060

Group type: EXPERIMENTAL
Intervention: L-glutamine ORS
Number of subjects: 147

Group type: COMPARATOR
Intervention: WHO-ORS
Number of subjects: 147
Study: 15893170

Group type: EXPERIMENTAL
Intervention: 30 mg folic acid
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12905551

Group type: EXPERIMENTAL
Intervention: Mesorectal excision
Number of subjects: 311

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 311
Study: 10608624

Group type: EXPERIMENTAL
Intervention: PRP‐T (Hib conjugate vaccine combined with DTP)
Number of subjects: 0
Study: 8768157

Group type: EXPERIMENTAL
Intervention: Vacuum splint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rigid backboard
Number of subjects: 0
Study: 1750637

Group type: EXPERIMENTAL
Intervention: Caudal blockade with bupivacaine 20 ml 0.5%
Number of subjects: 40
Study: 6785799

Group type: EXPERIMENTAL
Intervention: Carbamazepine (200-600 mg for 1 year)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Inert placebo
Number of subjects: 22
Study: 30677019

Group type: EXPERIMENTAL
Intervention: Free delivery of ORS prior to illness (free and convenient)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Home sales of ORS prior to illness (convenient only)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Free ORS upon retrieval using voucher (free only)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Status quo CHW distribution (control)
Number of subjects: 118
Study: 30448803

Group type: COMPARATOR
Intervention: 0.9% NaCl solution
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mannitol 15%
Number of subjects: 50
Study: 27264227

Group type: EXPERIMENTAL
Intervention: Comprehensive customized intervention
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 2000
Study: 24814408

Group type: EXPERIMENTAL
Intervention: Immediate loading (G2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Delayed loading (G1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups (G1 and G2)
Number of subjects: 36
Study: 22358586

Group type: EXPERIMENTAL
Intervention: Punctal plugs
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-plug group
Number of subjects: 18
Study: 20850365

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/d) + calcium (500 mg/d) (n=23)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo + calcium (500 mg/d) (n=23)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Untreated (n=12)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Any raloxifene treatment
Number of subjects: 125
Study: 17135218

Group type: EXPERIMENTAL
Intervention: TV‐IVC ablation +/‐ DC cardioversion (group B, n = 27)
Number of subjects: 57

Group type: COMPARATOR
Intervention: External cardioversion (group A, n = 30)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 57
Study: 16361623

Group type: EXPERIMENTAL
Intervention: Abdominoperineal resection (APR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anterior resection (AR)
Number of subjects: 0
Study: 12195168

Group type: EXPERIMENTAL
Intervention: Peak clipping hearing aid circuit
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Compression limiting hearing aid circuit
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Wide dynamic range compression hearing aid circuit
Number of subjects: 360

Group type: COMPARATOR
Intervention: Unaided condition
Number of subjects: 360
Study: 9607544

Group type: EXPERIMENTAL
Intervention: Gastric substitute (S-shaped pouch)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Total gastrectomy without gastric substitute
Number of subjects: 36
Study: 7618064

Group type: EXPERIMENTAL
Intervention: Fishermen
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Fishermen from the east coast
Number of subjects: 250

Group type: COMPARATOR
Intervention: Referents
Number of subjects: 250
Study: 2693406

Group type: EXPERIMENTAL
Intervention: Nimodipine 40 mg t.i.d.
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 703670

Group type: EXPERIMENTAL
Intervention: (+)-Cyanidanol-3 at a dosage of 6 tablets per day (3000 mg per day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: (+)-Cyanidanol-3 at a dosage of 3 X 1 tablet per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: (+)-Cyanidanol-3 at a dosage of 2 X 3 or 3 X 2 tablets per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: (+)-Cyanidanol-3 at all dose levels
Number of subjects: 0
Study: 31775729

Group type: EXPERIMENTAL
Intervention: DQTM tablet (Dan Qi Tong Mai tablet) at single doses of up to 5760 mg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: DQTM tablet (Dan Qi Tong Mai tablet) at twice-daily doses of up to 2160 mg for 14 consecutive days
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: DQTM tablet
Number of subjects: 84
Study: 27310527

Group type: EXPERIMENTAL
Intervention: Sulodexide (SDX) with Diosmin-Hesperidin (DH)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (Diosmin-Hesperidin (DH) only)
Number of subjects: 70
Study: 26522871

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise (45-50 min/week three times a week for four months) plus pharmacotherapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Only antidepressant medication
Number of subjects: 26
Study: 23625076

Group type: EXPERIMENTAL
Intervention: Radial to ulnar pattern of digit contact timing (DCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total contact time, frequency of first contacts by thumb and index fingers, number of simultaneous contacts
Number of subjects: 0
Study: 20948512

Group type: EXPERIMENTAL
Intervention: Behavioral and pharmacologic treatment
Number of subjects: 82
Study: 20439549

Group type: EXPERIMENTAL
Intervention: Omega-3 long-chain polyunsaturated fatty acid (omega3 LC-PUFA) supplementation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Omega-3 long-chain polyunsaturated fatty acid (omega3 LC-PUFA) supplementation with greater than 50% EPA
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Pure ethyl-EPA supplementation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Pure DHA supplementation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Supplements containing greater than 50% DHA
Number of subjects: 28
Study: 17335293

Group type: EXPERIMENTAL
Intervention: Induction chemoradiotherapy followed by surgical resection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsurgical therapy with chemoradiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induction therapy
Number of subjects: 0
Study: 15382984

Group type: EXPERIMENTAL
Intervention: Greater projection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less stereotyping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reaction time results
Number of subjects: 0
Study: 11300179

Group type: EXPERIMENTAL
Intervention: Overall community violence trends from A&E data collection
Number of subjects: 121475

Group type: EXPERIMENTAL
Intervention: Seasonal trends in community violence
Number of subjects: 121475
Study: 10331614

Group type: EXPERIMENTAL
Intervention: FRAXA premutation carriers with POF having low copy of the (TA)n polymorphism
Number of subjects: 52

Group type: COMPARATOR
Intervention: Familial POF
Number of subjects: 52

Group type: COMPARATOR
Intervention: FRAXA premutation carriers without POF
Number of subjects: 52
Study: 8589019

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg
Number of subjects: 966

Group type: COMPARATOR
Intervention: Granisetron 3 mg
Number of subjects: 966
Study: 2186058

Group type: EXPERIMENTAL
Intervention: MK-329 (10 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7194062

Group type: EXPERIMENTAL
Intervention: etofylline clofibrate 500 mg daily (2 x 1 capsule)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: etofylline clofibrate 750 mg daily (3 x 1 capsule)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: etofylline clofibrate (both dosages)
Number of subjects: 100
Study: 30691405

Group type: EXPERIMENTAL
Intervention: Multicomponent physical activity program (MEFAP) with twelve 1.5 h-weekly sessions
Number of subjects: 190

Group type: COMPARATOR
Intervention: Regular medical practice (Control)
Number of subjects: 190
Study: 28323916

Group type: EXPERIMENTAL
Intervention: Hydrocortisone infusion (0.2 mg/kg/min for 14 hours)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 17
Study: 25902326

Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane Block (TAPB)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Caudal Block
Number of subjects: 45
Study: 23870763

Group type: EXPERIMENTAL
Intervention: T‐shirt made of 100% polyester with 4 channels
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: T‐shirt made of 100% polyester with 6 channels
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: T‐shirt made of 100% polyester with 8 channels
Number of subjects: 8

Group type: COMPARATOR
Intervention: T‐shirt made of 100% cotton
Number of subjects: 8
Study: 21551990

Group type: EXPERIMENTAL
Intervention: Passive ankle dorsiflexion (PAD) for one minute
Number of subjects: 20
Study: 19852327

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.1 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal fentanyl 25 microg
Number of subjects: 60
Study: 16808927

Group type: EXPERIMENTAL
Intervention: 480 mg EGb 761
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 240 mg EGb 761
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 15448308

Group type: EXPERIMENTAL
Intervention: High elaboration during resistance to persuasion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low elaboration during resistance to persuasion
Number of subjects: 0
Study: 11820148

Group type: EXPERIMENTAL
Intervention: Orlistat treatment with diet
Number of subjects: 257
Study: 11570304

Group type: EXPERIMENTAL
Intervention: tissue plasminogen activator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: thrombolytic therapy
Number of subjects: 0
Study: 9260016

Group type: EXPERIMENTAL
Intervention: Light-guided retrograde intubation
Number of subjects: 27
Study: 8500240

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction (EF)
Number of subjects: 1446

Group type: EXPERIMENTAL
Intervention: Peak bicycle exercise oxygen consumption (VO2)
Number of subjects: 1446

Group type: EXPERIMENTAL
Intervention: Cardiothoracic ratio (CTR)
Number of subjects: 1446

Group type: EXPERIMENTAL
Intervention: Ventricular arrhythmias
Number of subjects: 1446

Group type: EXPERIMENTAL
Intervention: Plasma norepinephrine
Number of subjects: 1446

Group type: EXPERIMENTAL
Intervention: Plasma renin activity
Number of subjects: 1446
Study: 3694061

Group type: EXPERIMENTAL
Intervention: Visual correction using three anatomical points of reference (iliac crest levelness, vertical appraisal of the spine from the sacral base, levelness of the PSIS dimples)
Number of subjects: 41

Group type: COMPARATOR
Intervention: X-ray method of measurement
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Visual correction
Number of subjects: 41
Study: 1695314

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31754793

Group type: EXPERIMENTAL
Intervention: Combination therapy with pazopanib (800 mg daily for 1 week) and paclitaxel (80 mg/m2 weekly for 18 weeks) followed by maintenance pazopanib
Number of subjects: 14

Group type: COMPARATOR
Intervention: Single-agent pazopanib
Number of subjects: 14
Study: 31138317

Group type: EXPERIMENTAL
Intervention: Adaptive platform trials
Number of subjects: 0
Study: 28988307

Group type: EXPERIMENTAL
Intervention: Hypoxic-absolute exercise (HAT, 50%W max under 15%O2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hypoxic-relative exercise (HRT, 50% heart rate reserve under 15%O2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Normoxic exercise (NT, 50%W max under 21%O2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hypoxic control (HC, resting under 15%O2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normoxic control (NC, resting under 21%O2)
Number of subjects: 60
Study: 26254451

Group type: EXPERIMENTAL
Intervention: Fibrocaps plus gelatin sponge
Number of subjects: 175

Group type: COMPARATOR
Intervention: Gelatin sponge
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Fibrocaps
Number of subjects: 175
Study: 23645158

Group type: EXPERIMENTAL
Intervention: MgSO4 infusion (15 mg/kg/h)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 88